سعر لينكوبيوتيك 300 مجم 3 امبول 2022

Lincomycin 300 mg injection ampoules for intramuscular or intravenous use, a lincosamide antibiotic for serious Gram-positive infections.

• Serious infections due to susceptible strains of streptococci, pneumococci and staphylococci, reserved for penicillin-allergic patients or patients for whom a penicillin is inappropriate.Population: Adults and children over 1 monthDailyMed (U.S. National Library of Medicine)

• Gastrointestinal: diarrhoea, nausea, vomiting, glossitis, stomatitis, abdominal pain, anal pruritus; skin: rash, urticaria, pruritus and severe cutaneous reactions; blood: neutropenia, leukopenia, agranulocytosis, thrombocytopenic purpura, aplastic anaemia, pancytopenia; jaundice and raised transaminases; renal impairment, oliguria, proteinuria; hypotension, thrombophlebitis and cardio-respiratory arrest (with too-rapid IV use); vertigo, tinnitus, headache, dizziness, somnolence; injection-site pain, induration and sterile abscess.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to lincomycin or clindamycin.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Boxed warning: Clostridioides difficile-associated diarrhoea, ranging from mild diarrhoea to fatal colitis, may occur even more than two months after treatment; reserve lincomycin for serious infections where less toxic antimicrobials are inappropriate and do not use it for non-bacterial infections such as most upper respiratory tract infections.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Severe hypersensitivity reactions, including anaphylaxis and severe cutaneous adverse reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalised exanthematous pustulosis, erythema multiforme); discontinue and treat appropriately.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Cerebrospinal fluid concentrations may be inadequate for the treatment of meningitis.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Neuromuscular blocking agentsLincomycin has neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents; use with caution.DailyMed (U.S. National Library of Medicine)

• No adequate and well-controlled studies in pregnant women; use during pregnancy only if clearly needed. Lincomycin crosses the placenta (cord serum about 25% of maternal serum); experience in 345 obstetric patients showed no ill effects related to pregnancy, and no teratogenicity was seen in rats.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Lincomycin appears in human milk at 0.5 to 2.4 mcg/mL; because of potential serious adverse reactions in nursing infants, decide whether to discontinue nursing or the drug, taking into account the importance of the drug to the mother.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Lincomycin (as hydrochloride): Lincosamide antibacterial: binds the 23S RNA of the bacterial 50S ribosomal subunit and inhibits protein synthesis; predominantly bacteriostatic. Cross-resistance with clindamycin.